News

RBC Capital has once again stamped an "Outperform" rating on The Cigna Group, signaling steady analyst confidence. The price ...
The stock has lost 7.3% while the S&P 500 ... On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...
This was the stock's second consecutive day of losses.
The Cigna Group CI, a longstanding global health company, continues to offer a variety of health solutions and insurance ...
CVS Health CVS and The Cigna Group CI stand as two dominant forces in the U.S. diversified healthcare sector, commanding ...
Cigna trades at $313 per share and has moved almost in lockstep with the market over the last six months. The stock has lost ...
Citi initiated coverage of Aspen Insurance Holdings (AHL) with a Buy rating on Monday based on the insurer's recently ...
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated ...
Elevance Health runs a sprawling healthcare empire, but its stock seems to be in a full-body cast. Despite a strong Q1 ...
Martin has a “buy” rating and $145 price target for RDDT stock, which closed at $109.03 on May 29. Another one of the highest-ranked analysts in the WallStreetZen database is Wedbush analyst ...